Organovo Holdings Inc. (NYSEMKT:ONVO), a 3-D bioprinting technology company, announcement earlier this week it was collaborating with Yale School of Medicine, Department of Surgery to bring technology one step closer to bioprinting new tissues for human transplantation. With a waiting list for critical organ transplants are three to five times as long as the list of available organs, it is an important development. Organovo Holdings, Inc. (NYSEMKT:ONVO) in last trading activity moved down -7.71% to close at $5.39. Company weekly performance is -14.72% while its quarterly performance stands at -27.16%. Organovo Holdings, Inc. (NYSEMKT:ONVO) is -56.46% away from its 52 week high.
Ronald E. Klingle, Chairman of the Board of Avalon Holdings Corporation (NYSE: AWX), announced that effective December 1, 2014, Bryan P. Saksa, has been hired as Treasurer and Chief Financial Officer replacing Timothy C. Coxson. On last trading day Avalon Holdings Corp. (NYSEMKT:AWX) moved up 5.59% to close at $3.40. Its volatility for the week is 12.45% while volatility for the month is 3.96%. AWX’s sales growth for past 5 years was 4.00% and its EPS growth for past 5 years was -10.40%. Avalon Holdings Corp. (NYSEMKT:AWX) monthly performance is -0.87%.
Tronox Limited on 6 August 2014 reported second quarter 2014 revenue of $490 million compared to $525 million in the second quarter 2013. Second quarter revenue was $72 million higher than the $418 million produced in the first quarter 2014. Adjusted EBITDA was $108 million in the second quarter versus $101 million in the prior-year quarter and $77 million in the first quarter excluding a $13 million net lower of cost or market (LCM) charge. Adjusted net loss attributable to Tronox Limited in the second quarter was less than $100,000, or $0.00 per diluted share, versus an adjusted net loss of $15 million, or $0.13 per diluted share, in the year-ago quarter and an adjusted net loss of $58 million, or $0.51 per diluted share in the prior quarter. On last trading day Tronox Limited (NYSE:TROX) moved down -3.07% to close at $22.39. Its volatility for the week is 3.10% while volatility for the month is 3.52%. TROX’s sales growth for past 5 years was 9.10% and its EPS growth for past 5 years was -9.30%. Tronox Limited (NYSE:TROX) monthly performance is -3.66%.
Inovio Pharmaceuticals (NASDAQ:INO) announced the company and Roche (RHHBY) have terminated their 2013 collaboration, option, and license agreement to co-develop INO-5150, Inovios DNA immunotherapy targeting prostate cancer, as well as their research collaboration in prostate cancer. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has 2.80% insider ownership while its institutional ownership stands at 23.10%. In last trading activity company’s stock closed at $8.21.
Delta Air Lines, Inc. (NYSE:DAL) this week said it will break its two-cabin offerings into five classes of tickets: Delta One, formerly called BusinessElite, and first class up front; and Delta Comfort+, main cabin and Basic Economy in back. Delta Air Lines, Inc. (NYSE:DAL) in last trading activity moved down -0.24% to close at $46.22. Company weekly performance is 3.28% while its quarterly performance stands at 17.07%. Delta Air Lines, Inc. (NYSE:DAL) is -3.04% away from its 52 week high.